MiR-503 inhibits cell proliferation and induces apoptosis in colorectal cancer cells by targeting E2F3

International Journal of Clinical and Experimental Pathology

Volumn 8, Issue 10, 2015, Pages 12853-12860

  Chang, Shun Wu ^a,b   Yue, Jie ^b   Wang, Bao Chun ^b   Zhang, Xue Li ^a  

^a SOUTHERN MEDICAL UNIVERSITY   (China)

^b HAINAN PROVINCIAL PEOPLE S HOSPITAL   (China)

Author keywords

Apoptosis; Colorectal cancer; E2F3; MiR 503; Proliferation

Indexed keywords

E2F3 PROTEIN, HUMAN; MICRORNA; MIRN503 MICRORNA, HUMAN; TRANSCRIPTION FACTOR E2F3;

APOPTOSIS; CELL CYCLE; CELL PROLIFERATION; COLORECTAL TUMOR; DOWN REGULATION; GENE EXPRESSION REGULATION; GENETICS; HUMAN; METABOLISM; PATHOLOGY; SIGNAL TRANSDUCTION; TUMOR CELL LINE;

APOPTOSIS; CELL CYCLE; CELL LINE, TUMOR; CELL PROLIFERATION; COLORECTAL NEOPLASMS; DOWN-REGULATION; E2F3 TRANSCRIPTION FACTOR; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; MICRORNAS; SIGNAL TRANSDUCTION;

EID: 85013223194     PISSN: None     EISSN: 19362625     Source Type: Journal    
DOI: None     Document Type: Article

References (23)

1. Raskov H, Pommergaard HC, Burcharth J and Rosenberg J. Colorectal carcinogenesis-up date and perspectives. World J Gastroenterol 2014; 20: 18151-18164.
2. DeSantis CE, Lin CC, Mariotto AB, Siegel RL, Stein KD, Kramer JL, Alteri R, Robbins AS and Jemal A. Cancer treatment and survivorship statistics, 2014. CA Cancer J Clin 2014; 64: 252-271.
3. Arvelo F, Sojo F and Cotte C. Biology of colorectal cancer. Ecancermedicalscience 2015; 9: 520.
4. Chibaudel B, Tournigand C, Andre T and de Gramont A. Therapeutic strategy in unresectable metastatic colorectal cancer. Ther Adv Med Oncol 2012; 4: 75-89.
5. Scartozzi M, Giampieri R, Del Prete M, Faloppi L, Bianconi M, Vincenzi B, Tonini G, Santini D and Cascinu S. Selected gastrointestinal cancer presentations from the American Society of Clinical Oncology annual meeting 2013 in review: it is not about the destination, it is about the journey. Expert Opin Pharmacother 2014; 15: 143-150.
6. He L and Hannon GJ. MicroRNAs: small RNAs with a big role in gene regulation. Nat Rev Genet 2004; 5: 522-531.
7. Cui SY, Wang R and Chen LB. MicroRNA-145: a potent tumour suppressor that regulates multiple cellular pathways. J Cell Mol Med 2014; 18: 1913-1926.
8. Pasquinelli AE. MicroRNAs and their targets: recognition, regulation and an emerging reciprocal relationship. Nat Rev Genet 2012; 13: 271-282.
9. Orang AV and Barzegari A. MicroRNAs in colorectal cancer: from diagnosis to targeted therapy. Asian Pac J Cancer Prev 2014; 15: 6989-6999.
10. Griffiths-Jones S, Saini HK, van Dongen S and Enright AJ. miRBase: tools for microRNA genomics. Nucleic Acids Res 2008; 36: D154-158.
11. Zhao JJ, Yang J, Lin J, Yao N, Zhu Y, Zheng J, Xu J, Cheng JQ, Lin JY and Ma X. Identification of miRNAs associated with tumorigenesis of retinoblastoma by miRNA microarray analysis. Childs Nerv Syst 2009; 25: 13-20.
12. Peng Y, Liu YM, Li LC, Wang LL and Wu XL. microRNA-503 inhibits gastric cancer cell growth and epithelial-to-mesenchymal transition. Oncol Lett 2014; 7: 1233-1238.
13. Chong Y, Zhang J, Guo X, Li G, Zhang S, Li C, Jiao Z and Shao M. MicroRNA-503 acts as a tumor suppressor in osteosarcoma by targeting L1CAM. PLoS One 2014; 9: e114585.
14. Zhang Y, Chen X, Lian H, Liu J, Zhou B, Han S, Peng B, Yin J, Liu W and He X. MicroRNA-503 acts as a tumor suppressor in glioblastoma for multiple antitumor effects by targeting IGF-1R. Oncol Rep 2014; 31: 1445-1452.
15. Wang Z, Ma B, Ji X, Deng Y, Zhang T, Zhang X, Gao H, Sun H, Wu H, Chen X and Zhao R. MicroRNA-378-5p suppresses cell proliferation and induces apoptosis in colorectal cancer cells by targeting BRAF. Cancer Cell Int 2015; 15: 40.
16. Qin J, Wang F, Jiang H, Xu J, Jiang Y and Wang Z. MicroRNA-145 suppresses cell migration and invasion by targeting paxillin in human colorectal cancer cells. Int J Clin Exp Pathol 2015; 8: 1328-1340.
17. Yang Y, Gu X, Zhou M, Xiang J and Chen Z. Serum microRNAs: A new diagnostic method for colorectal cancer. Biomed Rep 2013; 1: 495-498.
18. Dong Y, Yu J and Ng SS. MicroRNA dysregulation as a prognostic biomarker in colorectal cancer. Cancer Manag Res 2014; 6: 405-422.
19. Jafri MA, Zaidi SK, Ansari SA, Al-Qahtani MH and Shay JW. MicroRNAs as potential drug targets for therapeutic intervention in colorectal cancer. Expert Opin Ther Targets 2015; 1-19.
20. Humbert PO, Verona R, Trimarchi JM, Rogers C, Dandapani S and Lees JA. E2f3 is critical for normal cellular proliferation. Genes Dev 2000; 14: 690-703.
21. Huang L, Luo J, Cai Q, Pan Q, Zeng H, Guo Z, Dong W, Huang J and Lin T. MicroRNA-125b suppresses the development of bladder cancer by targeting E2F3. Int J Cancer 2011; 128: 1758-1769.
22. Xue J, Niu YF, Huang J, Peng G, Wang LX, Yang YH and Li YQ. miR-141 suppresses the growth and metastasis of HCC cells by targeting E2F3. Tumour Biol 2014; 35: 12103-12107.
23. Li X, Li H, Zhang R, Liu J and Liu J. MicroRNA-449a inhibits proliferation and induces apoptosis by directly repressing E2F3 in gastric cancer. Cell Physiol Biochem 2015; 35: 2033-2042.